Summary. The proliferation of the human promonocytic leukemia cell line U937 is inhibited by several ether lipids, ether lipid analogues and by phorbol esters. An early effect of this retardation of cell growth is the induction of a basic chromosomal protein, histone Hl~ Northern blot analysis of H1 ~ mRNA levels reveals an increase of the mRNA concentration within a few hours after addition of hexadecylphosphocholine and 1-O-octadecyl-2-Omethyl-rac-glycero-3-phosphocholine. This early effect on the synthesis of a subtype of H1 proteins precedes the expression of several parameters of the monocytic differentiation of U937 cells.
Introduction
The alkyllysophospholipid 1-O-octadecyl-2-O-methylrac-glycero-3-phosphocholine (ET-18-OCH3) and the alkylphosphocholine hexadecylphosphocholine (He-PC) show a variety ofbiological properties. Besides activation of macrophages (Munder et al. 1976 ) and modulation of interleukin-1 and -2 secretion by lymphocytes (Andreesen et al. 1987 ) these compounds possess pronounced * Dedicated to Professor Dr. D. Schm~ihl on the occasion of his 65th birthday ** Supported by the Deutsche Forschungsgemeinschaft (D.D.) and the Ministry for Research and Technology (C.U.) Abbreviations: ES-16-OH, 1-O-palmitoyl-sn-glycero-3-phosphocholine, hexadecylphosphocholine; TPA, N, -hexanol Offprint requests to: C. Hochhuth, Medizinische Univ.-Klinik, Abt. H/imatologie/Onkologie, Robert-Koch-Str. 40, D-3400 G6ttingen, FRG dose-dependent antiproliferative activity in vitro and in vivo (Berdel et al. 1981; Munder et al. 1981; Vehmeyer et al. 1989; Muschiol et al. 1987; Hilgard et al. 1988) . Moreover, these compounds can induce differentiation of leukemic cell lines into mature myeloid cells (Honma et al. 1981 (Honma et al. , 1983 Hilgard et al. 1989) , and some data suggest that induction of differentiation may contribute to the in vivo antitumoral activity of He-PC in chemically induced rat mammary carcinomas (Hilgard et al. 1988) . The interaction and incorporation of these compounds within the cell membrane finally result in biological effects on several cellular processes, leading to an inhibition of DNA replication.
An arrest of DNA synthesis is frequently accompanied by changes of the pattern of chromosomal proteins (D'Anna et al. 1982; D'Incalci et al. 1986 ). Non-dividing, terminally differentiated cells, such as hepatocytes (Panyim and Chalkley 1969; Gabrielli et al. 1985; Gjerset et al. 1982) or nerve cells (Pina and Suau 1987; Pina et al. 1984) show an increased level of the H1 histone subtype HI ~ Unlike other histones, the synthesis of this subtype does not depend on DNA replication (Zlatanova 1980) , and it has been demonstrated in a variety of systems that several inhibitors of cell growth induce the de novo synthesis of this chromosomal protein (Zlatanova 1980; Chabanas et al. 1985; Pehrson and Cole 1980; Hall et al. 1985; Pieler et al. 1981) .
This correlation led to the initial suggestion that the presence of H1 ~ may be either a prerequisite or a consequence of an inhibition of DNA replication (van Helden 1985) . Induction of differentiation, however, has shown in several in vitro systems a de novo synthesis of HI o despite a continued DNA synthesis in these cultured cells (Alonso et al. 1988; Keppel et al. 1977) .
In this communication, we describe the kinetics of H1 ~ mRNA accumulation in the human promonocytic leukemia cell line U937 after addition of the alkyllysophospholipid ET-18-OCH 3 and the alkylphosphocholine He-PC. We demonstrate that the early effect on H1 o mRNA induction precedes an increase of markers of a monocytic differentiation.
Materials and methods

Materials.
Cell-culture materials were from Gibco/BRL (Gaithersburg Md.), enzymes were from Boehringer (Mannheim), chemicals for electrophoresis were from Serva (Heidelberg) denaturing agents were purchased from Fluka (Buchs, Switzerland). Other chemicals were from Merck (Darmstadt). Blotting membranes were from Amersham (Braunschweig) and Schleicher and Schfill (Dassel) . Anti HLA-DR, Leu3, LeuM3 and anti-(transferrin receptor) monoclonal antibodies were obtained from Becton Dickinson (Heidelberg). MOl and MO2 monoclonal antibodies were from Coulter (Krefeld). Nitroblue tetrazolium and 12-O-tetradecanoylphorbol 13-acetate (TPA) were purchased from Sigma (Mfinchen). , hexadecylphosphocholine (He-PC) and hexadecylphospho-(N, N, N-trimethylamino)-hexanol (He-PC6) were synthesized as previously described (Eibl 1981) . The chemical structures of the different compounds are given in Fig. 1 . The substances were dissolved in methanol/chloroform, dried under nitrogen and redissolved in serum-free RPMI-1640 medium. These stock solutions were sonicated for 10 min just before use.
Ether phospholipids and phospholipid analogues. 1-O-Palmitoyl-sn-
Phorbol ester (TPA) was dissolved in RPMI-1640 medium as a stock solution and was added to the cell culture (final concentration 32 nM).
Cell culture. Human promonocytic leukemia U937 cells were continuously cultured in RPMI-1640 medium, supplemented with 10% fetal calf serum, penicillin/streptomycin (100 units/ml and 100 p.g/ ml, respectively) and glutamine (2 mM) at 37 ~ C, 5% CO2. Cells were seeded at a density of 2 x 10 87 cells/ml and incubated in the presence or absence of test substances for different periods of time.
ES-16-OH
o u H2 9 O-C-(CH)14-CH 3 Fig. 1 . Chemical structures of phospholipids and phospbolipid analogues Cells were then collected and washed in fresh medium. Cell number and viability was determined in a Neubauer chamber by trypan blue dye exclusion.
HC-OH
RNA analysis. Cells were washed twice in ice-cold phosphate-buffered saline (0.14 M NaC1, 2.5 mM KC1, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pli 7.4) and total cellular RNA was prepared by the guanidinium isothiocynate/CsC1 method (Chirgwin et al. 1979 and hybridized with labeled DNA probes as previously described (Kress et al. 1986 ). Endogenous ribosomal RNA could be used as a marker, since human Hl ~ mRNA, being about 2.3 kb in length , has a size intermediate between 28S and 18S RNA, whereas main-group H1 measures around 0.7 kb (Eick et al. 1989) . DNA probes were derived from the buman HI ~ gene , from two human main-type H1 genes (Eick et al. 1989 ) and from human core histone genes (Eick and Doenecke, unpublished results) . After labeling the DNA fragments by nick translation (Rigby et al. 1977) , the probes were used for hybridization.
Analysis of surface antigen expression. Quantification of surface an-
tigen expression by flow cytometry was performed by direct immunofluorescence staining with fluorescein-isothiocyamate(FITC-conjugated monoclonal antibodies against human CDI4 (LeuM3, MO2), CD4 (Leu4), CDll (MOI) and HLA-DR antigen. The transferrin-receptor antigen was quantified by indirect immunofluorescence using a FITC-conjugated goat anti-(mouse Ig) monoclonal antibody.
Nitroblue tetrazolium reduction assay. A sample of 3 x l0 6 cells were suspended in I ml medium. An equal volume of 0.2% nitroblue tetrazolium dissolved in phosphate-buffered saline was added. After 45 min of incubation at 37 ~ C aliquots were taken and the percentage of cells containing formazan deposits was determined in a Neubauer chamber. The remaining cells were pelleted and lysed by addition of Triton X-•00 and sonication. Lysates were pelleted again at 2500 g. Supernatants were analyzed in a Hitachi U-2000 spectrophotometer at 560 nm.
Results
Effects of phospholipids, alkylphosphocholines and phorbol ester on U937 cell proliferation
U937 celts are derived from a human promonocytic leukemia (Sundstr6m and Nilsson 1976) . They can be induced to differentiate towards monocyte-like cells upon addition of a number of different compounds like phorbol ester (Gidlund et al. 1981) , retinoic acid (Ways et al. 1988 ) interferon 7 (Ralph et al. 1983 ), colony-stimulating factors (Geissler et al. 1989 ) and turnor necrosis factor OE (Trinchieri et al. 1986 ). Typically, these U937 cells cease to proliferate and, being treated with some substances, become attached to culture-vessel walls.
We have treated U937 cells with TPA, the alkyllysophospholipid ET-18-OCH 87 the acyllysophospholipid ES-16-OH and the two alkylphosphocholines He-PC and He-PC 6. Figure 2 shows the influence of these compounds on U937 cell growth. During an initial phase of 24 h cell division does not occur. Subsequently, control cells start to divide resulting in a fourfold cell number at 48 h. Cells treated with E T -/ 8 -O C H 8 7 He-PC and TPA, however, do not proliferate, whereas those treated with ES-16-OH and He-PC 6 show growth characteristics similar to control cells.
Effects of phospholipids, alkylphosphocholines and phorbol ester on H1 histone gene expression
The synthesis of the majority of histones is tightly coupled to D N A synthesis. In addition to these replication-dependent histones, a few subtypes are synthesized at a basal rate throughout the cell cycle. One of these replacement histones is the H 1 subtype H1 ~ We have analyzed the expression of the human H l~ histone gene in comparison with two genes coding for main-type H1 histones (Eick et al. 1989) . Human D N A probes coding for these histones had been isolated previously from a human genomic library (Eick et al. 1989 ). In addition, the m R N A coding for a core histone (H 2 A) was analyzed with the respective human gene probe. . Steady-state levels of mRNA coding for histone H 1~ and cellcycle-dependent histone species. RNA was extracted at different times (top line, la) after addition of hexadecylphosphocholine (HePC, 25 gM). Identical amounts of RNA (10 gg) were separated electrophoretically, blotted and hybridized witb 3Zp-labeled probes, derived from genes coding for histone H1 ~ (Doenecke and T6njes 1986), two different H1 histones (Eick et al. 1989 ) and an H2A core histone gene. The vertical arrow indicates removal of He-PC, washing and resuspension of the cells in He-PC-free medium R N A coding for the replication-dependent histones HI ~, H111 and H2A reflect the growth kinetics as presented in Fig. 2 . During the first 6 h after exposure to He-PC, the m R N A levels are just marginally reduced. Then the steady-state m R N A concentrations drop and even a removal of the growth-inhibiting compound does not cause a recovery of the expression of these genes within the next 8h.
In contrast to the replication-dependent H 1 und H2A histone genes, the H1 o gene expression is stimulated upon addition of He-PC as early as 1 h after exposure to the compound. The accumulation of the H1 ~ m R N A is reversed upon removal of He-PC and nearly reaches the basal level 8 h after resuspending the cells in control medium.
Thus, we conclude that He-PC affects the synthesis of replication-dependent and replacement histones in opposite directions. Removal of the antineoplastic compound leads to an immediate reversal of the HI ~ accumulation, whereas the decrease of the replication-dependent histone m R N A concentration remains unchanged. These kinetics hot only describe an He-PC-mediated effect on gene expression, but again demonstrate that the two types of histone are regulated independently.
The results obtained with ET-18-OCH 3 support the data described for He-PC. Figure 4 shows m R N A levels of U937 cells treated for different periods of time with ET-18-OCH 3. Again, the levels o f m R N A , coding for the subtypes H I I and H1 n drop after 6-12 h of treatment, whereas the level of H1 ~ m R N A increases steadily and reaches a maximum 12 h after the beginning of the treatment. Continued exposure to ET-18-OCH3, which causes a decrease ofthe number of viable cells after 12 h of treatment, then results in a decrease of the H1 o mRNA.
As shown in Figure 2 , ES-16-OH and He-PC6 do hot influence the growth kinetics of U937 cells. This lack of antiproliferative action agrees with the Northern blot results obtained with these substances. Figure 5 summarizes results obtained with one of these compounds, the acyllysophospholipid ES-16-OH. In this case, the levels of the replication-dependent m R N A species H 11 and H1 ii drop slightly during the first hours of treatment. After recovery from this initial inhibitory effect, the m R N A concentrations return to their initial levels. The H10 m R N A steady-state values, on the other hand, vary slightly during the initial hours of ES-16-OH treatment, but the substance elicits neither stimulatory nor inhibitory effects on the H1 ~ gene expression.
Phorbol ester is known to induce differentiation of U937 towards macrophage-like cells (Gidlund et al. 1981) . Figure 2 demonstrates that this is accompanied by an inhibition of cell division. Thus, TPA treatment of U937 cells provides a system to monitor the correlation between inhibition of D N A replication and H1 ~ induction. Figure 6 shows that the level of H1 ~ m R N A in- creases upon treatment of U937 cells with TPA. The mRNA concentration drastically rises at the third day of treatment (i. e. with a longer lag period than with the phospholipids described above). Washing the cells after 48 h of TPA treatment does not interfere with the induction process initiated by TPA, as the H10 mRNA concentration increases for the next 3 days. The H111 subtype of H1 shows mRNA level changes as expected for a replication-dependent histone subspecies in decreasing upon addition of TPA. This gradual decrease of the H1 mRNA concentration reflects the inhibition of cell proliferation. Even washing the cells after 48 h does not interrupt this decay.
Effects of phospholipids, alkylphospholines and phorbol ester on nitroblue tetrazolium reduction
During the course of differentiation U937 cells change their pattern of membrane antigen expression towards a monocyte-like phenotype. This includes the acquisition of CD14 (Hass et al. 1989; Nona et al. 1989 ), CD11 (Hass et al. 1989; Cabanas et al. 1988 ) and HLA-DR antigen (Aranzana-Seisdedos et al. 1988; Testa et al. 1988 ). On the other hand, transferrin receptors (Hass et al. 1989; Sheta et al. 1988 ) and CD4 antigen (Faltynek et al. 1989; Larsson et al. 1988) , as typical markers for early stages of the myeloic lineage, are reduced or lost. Table 1 summarizes the influence ofTPA, He-PC and ET-18-OCH 3 on surface antigen expression. These compounds in general seem to have quite similar effects. They 463 all enhance CD14 and CDI 1, whereas expression of CD4 antigen and transferrin receptor is diminished. There are, however, striking quantitative differences in antigen expression levels induced by these compounds. TPA, for instance, strongly enhances CD11, but has weak effects on CD14. In contrast, He-PC and ET-18-OCH 3 primarily enhance CD14 and marginally change CDll levels.
After TPA treatment U937 cells lose almost 85% of their CD4 antigens and about 50% of their transferrin receptors.
He-PC treatment elicits just small changes of both antigens while ET-18-OCH 3 decreases transferrin receptors to about 15% of control values.
He-PC 6 and ES-16-OH-treated cells show no significant difference of antigen expression pattern and quantity compared to control cell cultures.
Though HLA-DR induction and expression could have been expected during U937 differentiation (Aranzana-Seisdedos et al. 1988; Testa et al. 1988) we were unable to detect any membrane expression of this antigen. There is some evidence that the membrane transfer mechanism for cytoplasmatic HLA-DR proteins may be defective in some U937 cultures (Yunis et al. 1989 ).
Effects of phospholipids, alkylphosphocholines and phorbol ester on nitroblue tetrazolium reduction
Mature phagocytic cells, like macrophages and neutrophiles, are able to reduce nitroblue tetrazolium (Babior 1978) . In leukemia U937 cells nitroblue tetrazolium re- Table 1 . Change of surface antigen expression on U937 after 48 h of exposure to TPA, He-PC, ET-18-OCH 87 He-PC6, and ES-16-OH. Data represent mean fluorescence intensities determined by flow cytometry (mean of three independent experiments _+ SD)
268_+ 5 TPA50ng/ml 6• 2 51+ 9 46+_11 463_+29 137_+11 He-PC 10 gg/ml 31_+ 6 111_+18 218_+28 397_+20 173_+ 9 ET-18-OCH 87 5 gg/ml 47_+11 127_+10 217_+30 385_+37 39_+13 He-PC 6 10 gg/ml 5_+ 2 3_+ 1 316_+17 352_+10 349_+ 9 ES-16-OH 10 Ixg/ml 0 21_+ 5 333_+20 361_+17 344_+13
Table2. Nitroblue tetrazolium reduction capacity of U937 cells treated with TPA (50ng/ml), He-PC (5gg/ml), ET-18-OCH 3 (2 Bg/ml), He-PC6 (10 gg/ml) and ES-16-OH (10 gg/ml) for 48 h. (Geissler et al. 1989; Gavison et al. 1988) . As shown in Table 2 , TPA, He-PC and ET-18-OCH 3 increase the number of formazan-positive cells rive-to tenfold over control cell levels. In contrast, ES-16-OH and He-PC 6 have no effect on formazan formation. This could be obtained by counting nitroblue-tetrazoliumpositive cells in a Neubauer chamber as well as by spectrophotometric measurement of formazan content in the supernatant of lysed cells.
Discussion
The human promonocytic leukemia cell line U937 is inducible towards macrophage differentiation upon addition of several substances, such as phorbol ester, lymphokines, retinoic acid or calcitriol (Gidlund et al. 1981; Koeffler et al. 1980; Koeffler 1983) . We have treated U937 cells with hexadecylphosphocholine (He-PC) and
1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocho-
line (ET-18-OCH3), two lipids with well-known cytostatic and cytotoxic properties. These compounds were compared with phorbol ester and two other lipids lacking antiproliferative activity with respect to several parameters of growth inhibition and differentiation.
The H1 histone subtype HI ~ has been first described as a characteristic feature of the chromatin of non-dividing cells, as in adult liver (Panyim and Chalkley 1969; Gabrielli et al. 1985) or in a variety ofcell lines upon inhibition of DNA replication (Zlatanova 1980; Chabanas et al. 1985; Pehrson and Cole 1980; Hall et al. 1985; Pieler et al. 1981) . Exceptions to this apparent correlation between a repression of DNA synthesis and an induction of H1 o gene expression have been described in the meantime in Ehrlich ascites tumor cells (Banchev et al. 1988; Bouterfa et al. 1990) , in erythroleukemia cells (Keppel et al. 1977; Osborne and Chabanas 1984) , in mouse teratocarcinoma cells (Alonso et al. 1988 ) and in developing tissues in vivo (Gjerset et al. 1982) . The human hepatoma cell line HepG2, for example, expresses the H1 o gene constitutively at a high level (Gabrielli et al. 1985; Hochhuth and Doenecke 1990) , irrespective of the state of DNA replication (Hochhuth and Doenecke 1990 ).
An established system of induction of cell differentiation in leukemia cell lines is the macrophage type of development of TPA-treated U937 cells (Gidlund et al. 1981) . We have shown that this tumor cell system reacts to phorbol ester treatment by changing three parameters: the proliferation rate decreases, the steady-state level of H1 o mRNA increases and markers of macrophage-type differentiation are induced.
This correlation between an increase of the level of HI ~ and the differentiation of a particular cell type had been initially documented at the protein level in Friendvirus-transformed erythroleukemia cells (Keppel et al. 1977) . In the meantime, Cheng and Skoultchy (1989) demonstrated a rapid induction of H 1 o mRNA and a second H1 mRNA (1.8 kb in length) in mouse erythroleukemia cells. In that case, the induction of both mRNAs was negatively regulated by the DNA-binding c-myc protein. Lord et al. (1990) demonstrated in murine myeloid cells that an increased expression of the HI ~ gene is an intrinsic part of the immediate early response of these cells to terminal differentiation and to growth arrest stimuli. In that system, induction of myeloid cell differentiation did not just enhance the synthesis of H1 ~ but the expression of a second (cell-cycle-independent) replacement histone gene (H3.3) was equally
observed. An additional element of this early genetic response of myeloid cells was a stable induction ofjunB, a nuclear transcription factor. Thus, modulations in the structure of chromatin and direct effects on the transcription system parallel and precede individual steps of differentiation and growth arrest.
The antineoplastic lipids He-PC and ET-18-OCH 3 induce an increased expression of the H1 o gene 3-6 h af ter addition to the culture medium. This early accumulation of H1 ~ mRNA paralMs the inhibition of DNA replication caused by these compounds. Northern blot analysis of the same RNA preparations with probes for replication-dcpendent H1 and core histone subtypes shows the differential regulation of the replacement (Smith et al. 1984) histone H1 ~ versus the replication-dependent histones, which decrease upon inhibition of DNA replication. TPA essentially causes the same changes as the antineoplastic phospholipids on HI ~ synthesis, but with a prolonged lag period.
By contrast, the two other lipids ES-16-OH and He-PC~, which lack antitumoral activity, have no effect on cell proliferation, H1 ~ gene expression and membrane antigen expression. It should be mentioned, however, that both compounds when compared to ET-18-OCH 3 and He-PC, show very similar physical properties with respect to oil/water partition coefficients (log p values), critical micelle concentrations and induction ofhemolysis in human erythrocytes (Unger and Eibl 1990; Unger 1989) . Thus, despite the similarity of physical properties of the four lipids, only the two compounds with antitumoral activity show the described biological effects in the U937 cell line. The results presented here indicate that the antineoplastic phospholipids provide a novel system to investigate this correlation. It has been shown before that both substances lead to an inhibition of growth (Berdel et al. 1981; Munder et al. 1981; Vehmeyer et al. 1989; Muschiol et al. 1987; Hilgard et al. 1988) and to an induction of differentiation (Honma et al. 1981; 1983; Hilgard et al. 1989) . The induction of expression of the H1 ~ histone gene is a very early step, which precedes the expression of macrophage markers and parallels the antiproliferative action of the phospholipid compounds. It has been shown, on the other hand, that inhibition of replication and H1 ~ induction are independent processes. Thus, we may conclude that the partial restructuring of chromatin, as indicated by the accumulation of H1 ~ is one essential step contributing to the chain of events triggered by alkyllysophospholipids and alkylphosphocholines.
